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Physical Examination Findings
The patient's examination revealed a confused, disoriented, middle-aged woman, who appeared in no distress. Her vital signs were as follows: temperature, 35.9 C; heart rate, 106 beats/min, regular; BP, 121/ 75 mm Hg; respiratory rate, 32 breaths/min; and oxygen saturation, 99% on room air. Skin examination revealed ecchymotic plaques involving the nasal bridge, left maxillary region, and temple (Fig 1) . Also noted were multiple bilateral erythematous to violaceous patches, 1 to 5 cm in size, in the lower extremities (Fig 2) . Neurological examination was nonfocal. The patient had full nuchal range of motion and no evidence of neck rigidity. Her reflexes were normal, and plantar response was present and symmetric. The remainder of the examination was unremarkable.
Diagnostic Studies
The patient's WBC count was 27,500 U/L (neutrophils, 89.2%; lymphocytes, 2.2%; and eosinophils, 0%) with normal hemoglobin and platelet levels. Her BUN level was 57 mg/dL, and her creatinine level was 8 mg/dL. Creatine kinase was elevated at 16,665 U/L. Liver enzyme levels were mildly elevated (aspartate aminotransferase, 375 U/L; alanine aminotransferase, 156 U/L; and alkaline phosphate, 125 U/L). C-reactive protein levels were elevated to 497.4 mg/L. Cytoplasmic antineutrophil cytoplasmic antibody (c-ANCA) was positive, and perinuclear antineutrophil cytoplasmic antibody (p-ANCA) was negative. Cryoglobin, antinuclear antibody (ANA), complement 3, and complement 4 were within normal limits. Results of blood cultures were negative, and the urine toxicology screen was positive for cocaine. A CT scan of the head did not reveal any acute abnormalities. Results of a left lower extremity skin punch biopsy showed sparse perivascular and periadnexal, superficial to mid-dermal infiltrate of neutrophils and lymphocytes, with focal leukocytoclasis and tissue degenerative changes. Direct immunofluorescence was negative for IgG, IgA, IgM, complement 3, and fibrinogen deposition. The periodic acid-Schiff stain was negative for definitive fungal elements.
What is the most likely diagnosis? 
Answer: Levamisole-contaminated cocaine vasculitis
Discussion
Recreational use of cocaine is rising. The incidence of levamisole-contaminated cocaine vasculitis has been progressively growing, secondary to its increased use as an adulterant in the manufacturing of cocaine. Levamisole is an antihelminthic drug that has also been used as an immunomodulatory agent. In addition to being used as a bulking agent for cocaine, it potentiates its overall stimulant effect.
The characteristic clinical presentation of levamisolecontaminated cocaine vasculitis includes a constellation of nonspecific symptoms such as fever, chills, arthralgias, myalgias, and night sweats, as well as specific cutaneous manifestations. These cutaneous manifestations consist of ecchymotic/purpuric plaques with central necrosis in a retiform pattern, typically affecting the tip of nose, zygomatic arch, chin, and tips of the ears. Other locations include the tips of fingers and lower extremities. Lesions can resemble small-vessel vasculitis, septic vasculitis, antiphospholipid antibody syndrome, cryoglobulinemia, or warfarin-induced cutaneous necrosis. Notable hematologic abnormalities can include life-threatening neutropenia and agranulocytosis. In individuals with skin lesions, associated hematological abnormalities such as agranulocytosis occur in approximately 60%.
The pathogenesis of levamisole-induced vasculitis, including the generation of autoantigens and vasculitic purpura, remains unknown. Levamisole-contaminated cocaine vasculitis has been associated with the generation of autoantibodies, such as ANCA, ANA, and lupus anticoagulant. One case series reported that p-ANCA was elevated in 88%, whereas c-ANCA was elevated in 21%, and ANA was elevated in 51% of patients. Antibodies to human neutrophil elastase (anti-HNE) are elevated in patients with levamisolecontaminated cocaine vasculitis but not in those with small-vessel vasculitis. Common histopathological findings include a cutaneous vasculopathy that exhibits microvascular thrombosis with or without leukocytoclastic vasculitis and extensive interstitial and perivascular neovascularization.
Diagnosis is usually clinical. A diagnostic dilemma arises when the use of cocaine cannot be confirmed. Testing for levamisole is often difficult due to its short half-life of 5 to 6 h and requirement for testing via gas chromatography-mass spectrometry within 36 to 48 h of last cocaine use. Differentiation from small-vessel vasculitis can be challenging. Other vasculitic processes need to be ruled out, and thus a serological evaluation is essential. Because these lesions are associated with positive serologic findings such as positive p-ANCA and c-ANCA, the presence of anti-HNE may be used to differentiate levamisole-contaminated cocaine vasculitis from other small-vessel vasculitis.
Another distinct syndrome described in association with cocaine is cocaine-induced midline destructive lesions. These lesions reportedly occur in 4.8% of cocaine users. Destructive lesions are believed to occur secondary to local hypervasoconstriction, leading to hypoperfusion and subsequent mucosal and osteocartilaginous structures with involvement of the sinus and hard palate, with or without nasal septum perforation. Insufflation of cocaine crystals at high velocities leading to direct traumatic mucosal injury and recurrent local infections has been postulated as the causative mechanism. Anti-HNE is present in cocaine-induced midline destructive lesions as well and can help differentiate it from granulomatosis with polyangiitis, in which it is absent.
The mainstay of treatment for levamisole-contaminated cocaine vasculitis is complete abstinence from cocaine use, wound care, and avoidance of bacterial superinfection. Steroid therapy is not required. There are case reports of steroids being used in refractory cases in which the cutaneous lesions continued to develop despite cessation of cocaine use.
Clinical Course
The patient was treated with IV fluids and correction of electrolyte derangements. Her mental status and renal function were closely monitored. The patient's mental status, acute renal failure, and rhabdomyolysis improved with supportive care. She received wound care with vaseline-gauze and sulfadiazine, and her skin lesions improved as well. Anti-HNE was not checked in this patient because the treating physicians were confident of their clinical diagnosis, with her urine toxicology screen showing positivity for cocaine, and the patient improving with supportive care and abstinence from cocaine. Her hospital course was complicated by septic shock with gram-negative bacteremia. Following appropriate antibiotic therapy, this condition resolved, and she was discharged home.
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Levamisole-contaminated cocaine vasculitis presents
with classic skin findings consisting of diffuse ecchymotic plaques involving the ears, face, nose tip, and extremities. It may be associated with severe neutropenia and agranulocytosis. 2. Levamisole levels can be confirmatory but are only useful if obtained between 36 and 48 h of last cocaine use due to the drug's short half-life. 3. The presence of anti-HNE can differentiate levamisolecontaminated cocaine vasculitis from other small-vessel vasculitides that can otherwise have overlapping features such as skin lesions and the presence of autoantibodies. 4. Mainstay of treatment is complete abstinence from cocaine use, wound care, and supportive care. In refractory cases, steroids can be used.
